#TitleMD TANBIR SAJIB Renata is expanding its global footprint with nearly 86 bioequivalent medicines planned for its portfolio by 2026. Today, the company is exporting cancer medicines around the globe. Renata continues to advance its belief that cancer patients in Bangladesh deserve world-class, affordable treatments without compromise on standards.